Lysosomal Acid Lipase DeficiencySymptoms, Doctors, Treatments, Advances & More
Lysosomal Acid Lipase Deficiency Overview
Learn About Lysosomal Acid Lipase Deficiency
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Barbara Burton is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Chicago, Illinois. Dr. Burton is rated as an Elite provider by MediFind in the treatment of Lysosomal Acid Lipase Deficiency. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Phenylketonuria (PKU), Mucopolysaccharidoses (MPS), and Cholesteryl Ester Storage Disease.
Anais Brassier practices practicing medicine in Paris, France. Ms. Brassier is rated as an Elite expert by MediFind in the treatment of Lysosomal Acid Lipase Deficiency. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Wolman Disease, Lysosomal Acid Lipase Deficiency, Cholesteryl Ester Storage Disease, Kidney Transplant, and Liver Transplant.
Office
Radhika Tripuraneni is a General Surgeon practicing medicine in Boston, Massachusetts. Dr. Tripuraneni is rated as an Elite provider by MediFind in the treatment of Lysosomal Acid Lipase Deficiency. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Lysosomal Acid Lipase Deficiency.
Summary: A multicenter real-world observational study of the prevalence, diagnostic pathways, and clinical characteristics of lysosomal acid lipase deficiency in pediatric and adolescent risk groups in the Russian Federation (HELIOS)
Summary: This is an observational, multi-center, international disease registry designed to collect longitudinal data and create a knowledge base that will be utilized to improve the care and treatment of patients with LAL Deficiency. Participation in the Registry by both physicians and patients is voluntary.